Richmond pharma company makes leadership appointments

Richmond-based pharmaceutical company Kaléo announced Tuesday five executive leadership appointments and promotions.

Joining Kaléo from Boston Scientific, where he served as the senior vice president of corporate compliance and privacy officer, Kevin Espinoza has been hired as chief compliance officer. He will oversee Kaléo’s operations. He has also previously worked with Forest Laboratories, Compliance Implementation Services, GlaxoSmithKline and Eli Lilly.

Kaléo’s previous vice president of access and trade, Allison Bridges, has been promoted as vice president and general manager of allergy and pediatrics. She will be responsible for directing channel strategy and execution. She previously worked for Donaldson, Lufkin and Jenrette, Harris Williams & Co. and Merrill Lynch. 

In other promotions, T.J. Childress, the company’s former director of finance, has been named as senior director of access and trade. He will oversee product delivery across Kaléo’s brands. He previously worked for Deloitte Consulting, McGuireWoods LLP and Circuit City.

Now responsible for Kaléo’s market access strategy is Tom Assalley, the pharma company’s newly appointed vice president of market access. He previously served as vice president at Eli Lilly, overseeing the national accounts business unit. 

Meera Mehta, who previously worked for Endo Pharmaceuticals, GlaxoSmithKline and Novartis, will oversee training sales representatives as director of sales training. 

“We are excited to welcome this new team of leaders to Kaléo,” Kaléo President and CEO Spencer Williamson said in a statement. “Each are highly accomplished in their field and bring unique skills to their roles. We look forward to partnering with them on our mission to provide life-transforming products that empower patients and their families to live fuller, bolder lives.”

Founded in 2005, Kaléo manufactures and markets epinephrine auto-injector AUVI-Q, as well as Evzio, a prescription medicine used to treat opioid emergencies, such as overdoses. 

Subscribe to Virginia Business.

Get our daily e-newsletter.